ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 664217 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 664217; 2) Community: the network communities that were significantly associated with the response to NSC 664217; 3) Molecule: the relationships between components within communities and NSC 664217; 4) MDR: the compounds that were significantly associated with the NSC 664217.

NSC Compound Enrichment Correlation
NSC 638748 Tetrakis(8-chinolineolato)titanium(IV)-tetrahydrochloride 0.0171490505199911 0.37959436
NSC 639981 Null 0.0171490505199911 0.42745306
NSC 645317 Sanguilutine pseudobase 0.0171490505199911 0.29602532
NSC 645330 11H-Benzo[a]carbazole-1,4-dione, 7,11-dimethyl- 0.0171490505199911 0.48010755
NSC 654379 ANTINEOPLASTIC-654379 0.0171490505199911 0.39760481
NSC 657270 (+/-) Ethyl trans-2-(3,4-dihydroxyphenyl) cyclopropane-carboxylate 0.0171490505199911 0.026005298
NSC 662784 Null 0.0171490505199911 0.42811652
NSC 679002 2-Butenedioic acid, 2-[3-[(ethoxycarbonyl)methyl]-2,4-dioxopyrimidin-1-yl]-, diethyl ester, cis- 0.0171490505199911 0.35721057
NSC 712733 Null 0.0171490505199911 0.33587338
NSC 728040 2-[4-(methoxy)phenyltio]-3-phenyl-5,7-diamino quinoxaline 0.0171490505199911 0.20081779
Total:121  Current:58    [First] [Prev] [Next] [Last]